{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Dr. Mali\u2019s Top 5 Predictions in Ophthalmology for 2021","description":"In this special episode, I sit down with this week\u2019s co-host, my wife Yasmin P. Mali, MD, to discuss my top 5 predictions in ophthalmology in the new year. Stay tuned for a special announcement at the end of the show.  Intro :14 In this episode :21 About Yasmin P. Mali, MD :35 Mali\u2019s first prediction: The human spirit and innovation will triumph over the headline-dominating COVID-19 1:16 Yasmin Mali\u2019s thoughts on the first predictions 2:58 Mali\u2019s second prediction: The competition battle lines will be drawn for ocular therapeutics in the most common eye disease markets 4:04 Thoughts on the potential products in 2021 6:25 Mali\u2019s third prediction: Increased use of artificial intelligence in clinical ophthalmology 8:18 Any advances in artificial intelligence for pediatric ophthalmology? 10:15 Mali\u2019s fourth prediction: Telemedicine platforms will still play a role in ophthalmology 11:24 Thoughts on telemedicine in the pediatric ophthalmology community 13:44 Mali\u2019s fifth prediction: Virtual ophthalmology conference options will remain present for the majority of 2021 15:17 Mali\u2019s thoughts on the virtual meetings attended in 2020 17:10 Mali\u2019s bonus announcement 18:34 Yasmin Mali\u2019s final words 18:48  Yasmin P. Mali, MD, is a board-certified ophthalmologist and fellowship trained pediatric ophthalmologist. Mali is currently faculty at Lake Erie College of Osteopathic Medicine in Bradenton, Florida. Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; grant\/research support from Alimera Sciences, Allergan\/AbbVie, Chengdu Kanghong Biotechnology, Genentech, Notal Vision, Regeneron and Santen; consulting for Alimera Sciences, Allergan\/AbbVie, Eyepoint Pharmaceuticals, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis and Sun Pharmaceuticals; and stock\/shareholder with AbbVie and Regeneron. Yasmin Mali, MD, reports no relevant financial disclosures. We\u2019d love to hear from you! Send your comments\/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN. ","author_name":"Eye Care Insider","author_url":"https:\/\/www.healio.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/17309159\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/91894202"}